Please use this identifier to cite or link to this item: http://hdl.handle.net/11452/34953
Full metadata record
DC FieldValueLanguage
dc.date.accessioned2023-11-20T13:32:54Z-
dc.date.available2023-11-20T13:32:54Z-
dc.date.issued2018-12-
dc.identifier.citationOruç, A. ve Ersoy, A. (2018). ''Transplantation opportunities of hepatitis C virus-seropositive patients on the kidney waiting list''. Transplantation Proceedings, 50(10), 3181-3184.en_US
dc.identifier.issn0041-1345-
dc.identifier.issn1873-2623-
dc.identifier.urihttps://doi.org/10.1016/j.transproceed.2018.04.044-
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S0041134518306146-
dc.identifier.urihttp://hdl.handle.net/11452/34953-
dc.description.abstractObjective. Besides severe organ shortage, hepatitis C virus (HCV) infection is an important obstacle for kidney transplantation because of long waiting times on deceased kidney donor waiting lists. We aimed to evaluate calling number of candidates according to HCV serology. Method. A total of 404 adults on the deceased donor waiting list invited for cadaveric transplantation was evaluated. Demographic data, waiting time, calling number for transplantation, and viral serology were obtained during the 6-year period. Results. Mean waiting duration and calling number of all patients were 42.7 +/- 34 months and 1.56 +/- 4.37 times, respectively. Twenty-six candidates had chronic HCV infection and 12 of 26 were HCV RNA-positive. Mean waiting duration and calling number in anti-HCV-positive candidates were significantly higher compared with anti-HCV-negative candidates (85.3 +/- 38.8 vs 39.8 +/- 31.6 months, and 10.8 +/- 10.3 vs 0.92 +/- 2.6 times, respectively; P < .001). Mean waiting duration and total calling number in HCV-RNA-positive candidates were significantly higher than in HCV-RNA-negative ones (107.5 +/- 7.5 vs 66.2 +/- 44.8 months; P = .018; 15 +/- 9.7 vs 7.3 +/- 9.8 times, respectively; P = .026). Conclusions. Chronic HCV infection is an important issue leading to longer waiting time on the list. Our observation showed that waiting durations of anti-HCV-positive candidates were longer than that of negative patients, although they had more frequent opportunity for transplantation.en_US
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectImmunologyen_US
dc.subjectSurgeryen_US
dc.subjectTransplantationen_US
dc.subjectAntiviral therapyen_US
dc.subjectDialysis patientsen_US
dc.subjectInfectionen_US
dc.subjectDiseaseen_US
dc.subjectRecipientsen_US
dc.subjectSurvivalsen_US
dc.subjectSafetyen_US
dc.subjectDonorsen_US
dc.subjectGraften_US
dc.subjectRNAen_US
dc.subject.meshAdulten_US
dc.subject.meshFemaleen_US
dc.subject.meshHepacivirusen_US
dc.subject.meshHepatitis C.en_US
dc.subject.meshChronicen_US
dc.subject.meshHumansen_US
dc.subject.meshKidney transplantationen_US
dc.subject.meshMaleen_US
dc.subject.meshMiddle ageden_US
dc.subject.meshTissue donorsen_US
dc.subject.meshTurkeyen_US
dc.subject.meshWaiting listsen_US
dc.titleTransplantation opportunities of hepatitis C virus-seropositive patients on the kidney waiting listen_US
dc.typeArticleen_US
dc.identifier.wos000454972000043tr_TR
dc.identifier.scopus2-s2.0-85047297587tr_TR
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/İç Hastalıkları Anabilim Dalı/Nefroloji Anabilim Dalı.tr_TR
dc.contributor.orcid0000-0002-0710-0923tr_TR
dc.contributor.orcid0000-0002-0342-9692tr_TR
dc.identifier.startpage3181tr_TR
dc.identifier.endpage3184tr_TR
dc.identifier.volume50tr_TR
dc.identifier.issue10tr_TR
dc.relation.journalTransplantation Proceedingsen_US
dc.contributor.buuauthorOruç, Ayşegül-
dc.contributor.buuauthorErsoy, Alparslan-
dc.contributor.researcheridAAH-5054-2021tr_TR
dc.contributor.researcheridAAH-4002-2021tr_TR
dc.identifier.pubmed29803528tr_TR
dc.subject.wosImmunologyen_US
dc.subject.wosSurgeryen_US
dc.subject.wosTransplantationen_US
dc.indexed.wosSCIEen_US
dc.indexed.scopusScopusen_US
dc.indexed.pubmedPubMeden_US
dc.wos.quartileQ4en_US
dc.contributor.scopusid55133912100tr_TR
dc.contributor.scopusid35612977100tr_TR
dc.subject.scopusSustained Virologic Response; Hepatitis C Virus; Antivirus Agenten_US
dc.subject.emtreePeginterferonen_US
dc.subject.emtreeRibavirinen_US
dc.subject.emtreeVirus RNAen_US
dc.subject.emtreeAdulten_US
dc.subject.emtreeAge distributionen_US
dc.subject.emtreeArticleen_US
dc.subject.emtreeChronic hepatitis Cen_US
dc.subject.emtreeControlled studyen_US
dc.subject.emtreeDeceased donoren_US
dc.subject.emtreeFemaleen_US
dc.subject.emtreeGenotypeen_US
dc.subject.emtreeHospital admissionen_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeKidney transplantationen_US
dc.subject.emtreeLiving donoren_US
dc.subject.emtreeMajor clinical studyen_US
dc.subject.emtreeMaleen_US
dc.subject.emtreeMiddle ageden_US
dc.subject.emtreePriority journalen_US
dc.subject.emtreeRetrospective studyen_US
dc.subject.emtreeSerologyen_US
dc.subject.emtreeSex ratioen_US
dc.subject.emtreeSustained virologic responseen_US
dc.subject.emtreeChronic hepatitis Cen_US
dc.subject.emtreeComplicationen_US
dc.subject.emtreeDonoren_US
dc.subject.emtreeHepacivirusen_US
dc.subject.emtreeKidney transplantationen_US
dc.subject.emtreeMortalityen_US
dc.subject.emtreeProceduresen_US
dc.subject.emtreeStatistics and numerical dataen_US
dc.subject.emtreeTurkey (bird)en_US
Appears in Collections:Scopus
Web of Science

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.